Novakand Pharma AB (publ) (FRA:3EE0)
Germany
· Delayed Price · Currency is EUR 0.0001
0.00 (0.00%)
At close: Dec 5, 2025
Novakand Pharma AB Market Cap
Novakand Pharma AB has a market cap or net worth of €1.76 million as of December 5, 2025. Its market cap has decreased by -84.02% in one year.
Market Cap
1.76M
Enterprise Value
-273.55K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.00
Market Cap Chart
Since February 28, 2011, Novakand Pharma AB's market cap has decreased from 10.30M to 1.76M, a decrease of -82.93%. That is a compound annual growth rate of -11.28%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 98.87B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.10B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |